Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 976 - 1000 of 1334 in total
Experimental
Matched Categories: … CDC2 Protein Kinase, antagonists & inhibitors …
GSK2636771 has been used in trials studying the treatment of CANCER, LYMPHOMA, Solid Neoplasm, Recurrent Solid Neoplasm, and Advanced Malignant Neoplasm, among others.
Investigational
Matched Categories: … Protein Kinase Inhibitors …
BMS-911543 has been used in trials studying the treatment of Cancer.
Investigational
Matched Categories: … Janus Kinase 2, antagonists & inhibitors …
Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.
Investigational
Matched Description: … It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent. …
Matched Categories: … Protein Kinase Inhibitors …
FF-10101-01 is under investigation in clinical trial NCT03194685 (Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
Investigational
Matched Iupac: … (2E)-N-[(1S)-1-[(5-{2-[(4-cyanophenyl)amino]-4-(propylamino)pyrimidin-5-yl}pent-4-yn-1-yl)carbamoyl]ethyl …
Matched Categories: … Protein Kinase Inhibitors …
Investigational
Matched Categories: … Protein Kinase Inhibitors ... Mammalian target of rapamycin (mTOR) kinase inhibitors …
AZD1480 has been used in trials studying the treatment of Solid Malignancies, Post-Polycythaemia Vera, Primary Myelofibrosis (PMF), and Essential Thrombocythaemia Myelofibrosis.
Investigational
Matched Categories: … Janus Kinase 2, antagonists & inhibitors …
Experimental
Experimental
Investigational
Matched Categories: … Protein Kinase Inhibitors ... Protein Kinase C, antagonists & inhibitors …
Quercetin is a flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.
Experimental
Investigational
Investigational
Experimental
Tideglusib is under the investigation for the development of treatments for Alzheimer's disease and for progressive supranuclear palsy. It is reported to be a potent anti-inflammatory and neuroprotective that is a non-ATP competitive inhibitor of glycogen synthase kinase 3 (GSK-3). Tideglusib is being developed by the Spanish pharmaceutic company Zeltia...
Investigational
Withdrawn
Matched Description: … anti-inflammatory and neuroprotective that is a non-ATP competitive inhibitor of glycogen synthase kinase
Matched Categories: … Glycogen Synthase Kinase 3, antagonists & inhibitors …
Emprumapimod is a potent, orally active and selective inhibitor of p38α mitogen-activated kinase inhibitor. It was investigated for dilated cardiomyopathy.
Investigational
Matched Description: … Emprumapimod is a potent, orally active and selective inhibitor of p38α mitogen-activated kinase inhibitor …
KC706 is a novel anti-inflammatory drug that works by inhibiting the activity of p38 MAP kinase. KC706 holds potential to treat inflammatory conditions such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and cardiovascular disease.
Investigational
Matched Description: … KC706 is a novel anti-inflammatory drug that works by inhibiting the activity of p38 MAP kinase. …
Experimental
Matched Categories: … Protein Kinase Inhibitors …
Experimental
Matched Categories: … Protein Kinase Inhibitors …
Investigational
Matched Categories: … Protein Kinase Inhibitors …
Experimental
Experimental
Equilenin is an estrogenic steroid produced by horses. It has a total of five double bonds in the A- and B-ring. High concentration of equilenin is found in the urine of pregnant mares.
Experimental
Investigational
Vet approved
Matched Categories: … Janus Kinase 1, antagonists & inhibitors …
Displaying drugs 976 - 1000 of 1334 in total